Monocyte chemoattractant protein 1 (MCP-1) gene polymorphism is not associated with severe and cerebral malaria in Thailand

Japanese Journal of Infectious Diseases

Volumn 59, Issue 4, 2006, Pages 239-244

  Dechkum, Naowarut ^a   Hananantachai, Hathairad ^a   Patarapotikul, Jintana ^a   Ohashi, Jun ^b   Krudsood, Srivicha ^a   Looareesuwan, Sornchai ^a   Tokunaga, Katsushi ^b  

^a MAHIDOL UNIVERSITY   (Thailand)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCYTE CHEMOTACTIC PROTEIN 1;

ADOLESCENT; ADULT; ARTICLE; BRAIN MALARIA; CONTROLLED STUDY; DISEASE SEVERITY; DNA EXTRACTION; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE SEQUENCE; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALARIA; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; THAILAND;

ADOLESCENT; ADULT; ALLELES; ANIMALS; CHEMOKINE CCL2; FEMALE; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; MALARIA, CEREBRAL; MALE; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; THAILAND;

EID: 33748094491     PISSN: 13446304     EISSN: 13446304     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Omer, F. M., Kurtzhals, J. A. and Riley, E. M. (2000): Maintaining the immunological balance in parasitic infections: a role for TGF-beta? Parasitol. Today, 16, 18-23.
2. Dodoo, D., Omer, F. M., Todd, J., Akanmori, B. D., Koram, K. A. and Riley, E. M. (2002): Absolute levels and ratios of proinflammatory and anti-inflammatory cytokine production in vitro predict clinical immunity to P. falciparum malaria. J. Infect. Dis., 185, 971-979.
3. Artavanis-Tsakonas, K., Eleme, K., McQueen, K. L., Cheng, N. W., Parham, P., Davis, D. M. and Riley, E. M. (2003): Activation of a subset of human natural killer cells upon contact with Plasmodium falciparum-infected erythrocytes. J. Immunol., 171, 5396-5405.
4. Clark, I. A. and Cowden, W. B. (2003): The pathophysiology of falciparum malaria. Pharmacol. Ther., 99, 221-260.
5. Medana, I. M., Chaudhri, G., Chan-Ling, T. and Hunt, N. H. (2001): Central nervous system in cerebral malaria: 'Innocent bystander' or active participant in the induction of immunopathology? Immunol. Cell Biol., 79, 101-120.
6. Medana, I. M., Hunt, N. H. and Chaudri, G. (1997): TNFα expression in the brain during fatal murine cerebral malaria: evidence for production by microglia and astrocytes. Am. J. Pathol., 150, 1473-1486.
7. Jennings, V. M., Actor, K. J., Lal, A. A. and Hunter, R. L. (1997): Cytokine profile suggesting that murine cerebral malaria is an encephalitis. Infect. Immun., 65, 4883-4887.
8. Ma, N., Madigan, M. C., Chan-Ling, T. and Hunt, N. H. (1997): Compromised blood-nerve barrier, astrogliosis, and myelin disruption in optic nerves during fatal murine cerebral malaria. Glia, 19, 135-151.
9. Ma, N., Hunt, N. H., Madigan, M. C. and Chan-Ling, T. (1996): Correlation between enhanced vascular permeability, up-regulation of cellular adhesion molecules and monocyte adhesion to the endothelium in the retina during the development of fatal murine cerebral malaria. Am. J. Pathol., 149, 1745-1762.
10. Jennings, V. M., Lal, A. A. and Hunter, R. L. (1998): Evidence for multiple pathological and protective mechanism in murine cerebral malaria. Infect. Immun., 66, 5972-5979.
11. Patnaik, J. K., Das, B. S., Mishra, S. K., Mohanty, S., Satpathy, S. K. and Mohanty, D. L. (1994): Vascular clogging, mononuclear cell margination, and enhanced vascular permeability in the pathogenesis of human cerebral malaria. Am. J. Trop. Med. Hyg., 51, 642-647.
12. Berendt, A. R., Turner, G. D. and Newbold, C. I. (1994): Cerebral malaria: the sequestration hypothesis. Parasitol. Today, 10, 412-414.
13. Gu, L., Tseng, S. C. and Rollins, B. J. (1999): Monocyte chemoattractant protein-1. Chem. Immunol., 72, 7-29.
14. Owens, T., Renno, T., Taupin, V. and Krakowski, M. (1994): Inflammatory cytokines in the brain: does the CNS shape immune responses? Immunol. Today, 15, 566-571.
15. Svetlana, M. S., Richard, F. K., Steven, L. K. and Anuska, V. A. (2003): Potential role of MCP-1 in endothelial cell tight junction "opening": signaling via Rho and Rho kinase. J. Cell. Sci., 116, 4615-4628.
16. Stamatovic, S. M., Shakui, P., Keep, R. F., Moore, B. B., Kunkel, S. L., Van Rooijen, N. and Andjelkovic, A. V. (2005): Monocyte chemoattractant protein- 1 regulation of blood-brain barrier permeability. J. Cereb. Blood Flow Metab., 25, 593-606.
17. Cinque, P., Vago, L., Mengozzi, M., Torri, V., Ceresa, D., Vicenzi, E., Transidico, P., Vagani, A., Sozzani, S., Mantavani, A., Lazzarin, A. and Poli, G. (1998): Elevated cerebrospinal fluid levels of monocyte chemotactic protein-1 correlate with HIV-1 encephalitis and local viral replication. AIDS, 12, 1327-1332.
18. Yamagami, S., Tamura, M., Hayashi, M., Endo, N., Tanabe, H., Katsuura, Y. and Komoriya, K. (1999): Differential production of MCP-1 and cytokine-induced neutrophil chemoattractant in the ischemic brain after transient focal ischemia in rats. J. Leukoc. Biol., 65, 744-749.
19. Mahad, D. J. and Ransohoff, R. M. (2003): The role of MCP-1 (CCL2) and CCR2 in multiple sclerosis and experimental autoimmune encephalitomyelitis (EAE). Semin. Immunol., 15, 23-32.
20. Szalai, C., Duba, J., Prohaszka, Z., Kalina, A., Szabo, T., Nagy, B., Horvath, L. and Csaszar, A. (2001): Involvement of polymorphisms in the chemokine system in the susceptibility for coronary artery disease (CAD). Coincidence of elevated Lp(a) and MCP-1 -2518G/G genotype in CAD patients. Atherosclerosis, 158, 233-239.
21. Gonzalez-Escribano, M. F., Torres, B., Aguilar, F., Rodriguez, R., Garcia, A., Valenzuela, A. and Nunez-Rolden, A. (2003): MCP-1 promoter polymorphism in Spanish patients with rheumatoid arthritis. Hum. Immunol., 64, 741-744.
22. Alonso-Villaverde, C., Coll, B., Parra, S., Montero, M., Calvo, N., Tous, M., Joven, J. and Masana, L. (2004): Atherosclerosis in patients infected with HIV is influenced by a mutant monocyte chemoattractant protein-1 allele. Circulation, 110, 2204-2209.
23. Rovin, B. H., Lu, L. and Saxena, R. (1999): A novel polymorphism in the MCP-1 gene regulatory region that influence MCP-1 expression. Biochem. Biophy. Res., 259, 344-348.
24. Modi, W. S., Goedert, J. J., Strarhdee, S., Goedert, J. J., Strachdee, S., Buchbinder, S., Detels, R., Donfield, S., O'Brien, S.J. and Winkler, C. (2003): MCP-1-MCP-3 Eotaxin gene cluster influences HIV-1 transmission. AIDS, 17, 2357-2365.
25. World Health Organization (2000): WHO Expert Committee on Malaria. 20th Report. WHO Tech. Rep. Ser., no. 892, 3-6.
26. Bux, J., Stein, E. L., Santoso, S. and Muller-Eckhardt, C. (1995): NA gene frequencies in the German population, determined by polymerase chain reaction with sequence-specific primers. Transfusion, 35, 54-57.
27. Excoffier, L. and Slatkin, M. (1995): Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. Mol. Biol. Evol., 12, 921-927.
28. Lewontin, R. C. (1988): On measures of gametic disequilibrium. Genetics, 120, 849-852.
29. Hill, W. G. and Robertson, A. (1968): Linkage disequilibrium in finite populations. Theor. Appl. Genet., 38, 226-231.
30. Ohashi, J., Yamamoto, S., Tsuchiya, N., Hatta, Y., Komata, T., Matsushita, M. and Tokunaga, K. (2001): Comparison of statistical power between 2 X 2 allele frequency and allele positivity tables in case-control studies of complex disease genes. Ann. Hum. Genet., 65, 197-206.
31. Peterson, P. K., Hu, S., Salak-Johnson, J., Molitor, T. W. and Chao, C. C. (1997): Differential production of and migratory response to beta chemokines by human microglia and astrocytes. J. Infect. Dis., 175, 478-481.
32. Guo, H., Jin, Y. X., Ishikawa, M., Huang, Y. M., van der Meide, P. H., Link, H. and Xiao, B. G. (1998): Regulation of β-chemokine mRNA expression in adult at astrocytes by lipopolysaccharide, proinflammatory and immunoregulatory cytokines. Scand. J. Immunol., 48, 502-508.
33. Hurwitz, A. A., Lyman, W. D. and Berman, J. W. (1995): Tumor necrosis factor alpha and transforming growth factor beta upregulate astrocyte expression of monocyte chemoattractant protein-1. J. Neuroimmunol., 57, 193-198.
34. Hanum, P. S., Hayano, M. and Kojima, S. (2003): Cytokine and chemokine responses in a cerebral malaria-susceptible or -resistant strain of mice to P. berghei ANKA infection: early chemokine expression in the brain. Int. Immunol., 15, 633-640.
35. Kossodo, S. and Grau, G. E. (1993): Profile of cytokine production in relation with susceptibility to cerebral malaria. J. Immunol., 151, 4811-4820.
36. Maneerat, Y., Pongponratn, E., Viriyavejakul, P., Punpoowong, B., Looareesuwan, S. and Udomsangpetch, R. (1999): Cytokine associated with pathology in the brain tissue of fatal malaria. Southeast Asian J. Trop. Med. Public Health, 30, 643-649.
37. Maneerat, Y., Viriyavejakul, P., Punpoowong, B., Jones, M., Wilairatana, P., Pongponratn, E., Turner, G. D. and Udomsangpetch, R. (2000): Inducible nitric oxide synthase expression is increased in the brain in fatal cerebral malaria. Histopathology, 37, 269-277.